United States: Scope Of Estoppel Post-IPR Proceedings Becoming Clearer

Under 35 U.S.C. §315(e)(1), a petitioner who files a petition for inter partes review (IPR) that proceeds to a final written decision "may not assert ... in a civil action ... that the claim [at issue in the IPR] is invalid on any ground that the petitioner raised or reasonably could have raised during that" IPR. This estoppel provision has been the subject of a number of Federal Circuit and district court decisions. Most of these decisions have interpreted §315(e)(1) narrowly and have recognized many circumstances where IPR arguments do not give rise to estoppel. One recent decision out of the Northern District of California—Verinata Health v. Ariosa Diagnostics, Case No. 12-cv-05501 (N.D. Cal., Jan. 19, 2017)—represents an exception to this general trend. Verinata held that §315(e)(1) can, in certain circumstances, apply to invalidity grounds included in an IPR petition that the Patent Trial and Appeal Board (PTAB) determined to be redundant and did not institute and carry through to a final written decision.

To help put Verinata in context, a summary of the state of the law regarding IPR estoppel prior to the decision follows.

Scope of IPR Estoppel Prior to 'Verinata'

There are several types of invalidity arguments that cannot be raised in an IPR at all. In particular, an IPR can only address "a ground that could be raised under section 102 or 103 and only on the basis of prior art consisting of patents or printed publication." 35 U.S.C. §311. Thus, it is not possible for a petitioner to raise §101, §112, or invalidity arguments based on prior use, sale, knowledge, or invention. See Synopsys v. Mentor Graphics , 814 F.3d 1309, 1316 (Fed. Cir. 2016). Since §315(e)(1) applies only to "ground[s] that the petitioner raised or reasonably could have raised," it follows that the issuance of an IPR final written decision cannot prevent a defendant from making these types of arguments in district court. See id. Indeed, some courts have found that a petitioner is not estopped from making on-sale bar or prior invention invalidity arguments even when there is some documentary overlap between those arguments and invalidity grounds that were part of an IPR. For instance, in Depomed v. Purdue Pharma, Case No. 13-571 (D.N.J. Nov. 4, 2016), the plaintiff attempted to argue that §315(e)(1) applied to defendant's on-sale bar and 102(g) defenses. See id. at 12.

With respect to the on-sale bar, the plaintiff argued that the defendant had access to "sufficient documentation" regarding the on-sale product that would have allowed this invalidity defense to be included in the defendant's earlier IPR. Id. at 13. With respect to 102(g), the patentee argued that the defense was premised on two publicly available patent applications that also could have served as the basis for an IPR ground. Id. The court disagreed that the on-sale and 102(g) defenses were barred. According to the court, "the use of patents or printed publications" to support such arguments does not "transform these defenses" into "a statutory ground for relief in an IPR." Id. at 16. Further, the court also noted that while the defendant did point to some published documents, many of the documents cited in support of the invalidity defenses were confidential. Id. at 17; see also Star Envirotech v. Redline Detection, Case No. 12-01861, at 5 (C.D. Cal. Jan. 29, 2015) (refusing to strike invalidity defense based on a prior sale despite the fact that the challenger had access to a printed user manual for the on-sale product when it filed an IPR because "the physical machine itself discloses features claimed in the [patent] that are not included in the instruction manual, and it is therefore a superior and separate reference").

Next, §315(e)(1) states that it applies when "inter partes review of a claim in a patent ... results in a final written decision." Interpreting this language, courts have determined that estoppel applies on a claim-by-claim basis. An IPR petitioner is not estopped from challenging the validity of any claims that were not at issue in IPR. See Synopsys, 814 F.3d at 1313-14.

Last, courts have also found that §315(e)(1) does not apply to an invalidity ground that was included in an IPR petition but not instituted. See Shaw Indus. Group v. Automated Creel Sys. , 817 F.3d 1293, 1300 (Fed. Cir. 2016). Estoppel does not apply because these non-instituted grounds do "not become part of an IPR" and thus "were not raised and, as review was denied, could not be raised in the IPR." HP v. MPHJ Tech. Invs. , 817 F.3d 1399, 1347 (Fed. Cir. 2016).

'Verinata'

The Verinata decision addresses many of the same factual circumstances discussed above and arrives at the same conclusions regarding the applicability of §315(e)(1). But, one additional factual scenario was also addressed: the Verinata court was confronted with an IPR invalidity ground that was not instituted, but was entirely subsumed within a ground that was instituted and proceeded to final written decision. Departing from the trend to interpret §315(e)(1) narrowly, Verinata found that §315(e)(1) can apply to this type of non-instituted ground.

In this case, plaintiff Verinata Health asserted two patents—U.S. Patent Nos. 8,318,430 (the '430 patent) and 7,955,794 (the '794)—against defendant Ariosa Diagnostics. Ariosa then filed a series of petitions for inter partes review. The district court granted a stay pending the resolution of the IPRs.

Ariosa's petition relating to the '430 patent asserted three grounds: (1) obviousness over Dhallan and Binladen, (2) obviousness over Quake and Criag, and (3) obviousness over references Dhallan, Binladen, and Shoemaker. The PTAB instituted IPR only on the third ground. The '794 petition also included three grounds (1) anticipation by Fan, (2) obviousness over Fan and Lizardi, and (3) obviousness over Straus, Rothberg, and Walt. The PTAB instituted IPR only on the first ground. Ariosa's two IPRs then proceeded to final written decision. In connection with the '430 patent, the PTAB rejected Ariosa's arguments because it found the evidence regarding motivation to combine lacking. In connection with the '794 patent, the PTAB found that Ariosa had failed to establish that Fan was prior art.

After the final written decision, the district court lifted the stay. Ariosa continued to pursue invalidity arguments tracking grounds (1) and (2) from the '430 IPR petition and grounds (1), (2), and (3) from its '794 petition. According to Ariosa, all but one of these invalidity arguments were "grounds for which it petitioned IPR but the PTAB did not institute trial" making 315(e)(1) inapplicable. While IPR had been instituted in connection with ground (1) in the '794 petition (anticipation by Fan), Ariosa argued that the PTAB's final written decision focused on a "technicality" and did not analyze "patentability" in a way that would give rise to estoppel. Verinata moved to strike all these invalidity defenses.

Following a number of Federal Circuit cases discussing §315(e)(1), including the Shaw decision cited above, the district court found that Ariosa was not estopped from pursuing invalidity arguments that tracked ground (2) from its '430 petition (obviousness over Quake and Craig), or grounds (2) and (3) in its '794 petition (obviousness over Fan and Lizardi, and obviousness over Straus, Rothberg, and Walt). The court explained that estoppel did not apply to these arguments because "the PTAB did not institute" IPR on these grounds. Id. at 7, 8-9. The court did, however, find that Ariosa was estopped from pursuing ground (1) from the '794 petition. While the court recognized that the PTAB "never specifically compared Fan with the challenged claims of the '794 patent," it nonetheless issued a final written decision in which it found that "failed to carry its burden to demonstrate that Fan was prior art under §102." Id. at 9-10. This is all that is required to trigger §315(e)(1).

These decisions are consistent with and very closely track past Federal Circuit and district court rulings. The Verinata court also determined, however, that Ariosa was estopped in connection with ground (1) from the '430 petition (obviousness over Dhallan and Binladen). The district court recognized that the "PTAB did not institute on this exact ground" because it viewed it as "redundant" of the Dhallan, Binladen, and Shoemaker. Id. at 7. Estoppel does not typically apply to non-instituted grounds. Regardless, the district court found the combination of Dhallan and Binladen to be "simply a subset of the instituted grounds." Id. Thus, the court held that Ariosa had effectively raised obviousness over references Dhallan and Binladen during IPR and was estopped from continuing to pursue invalidity arguments based on those two references in district court. Id. at 7-8.

In sum, while §315(e)(1) has been interpreted relatively narrowly, the Verinata decision provides patent owners with a new avenue to argue—in certain circumstances—that an IPR petitioner should be estopped from asserting non-instituted IPR grounds in district court.

Originally published by New York Law Journal © 2017 ALM Media Properties, LLC.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.